BCM
BML Capital Management Portfolio holdings
AUM
$131M
This Quarter Return
-23.11%
1 Year Return
+89.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$124M
AUM Growth
+$124M
(-23%)
Cap. Flow
-$2.83M
Cap. Flow
% of AUM
-2.29%
Top 10 Holdings %
Top 10 Hldgs %
86.46%
Holding
31
New
6
Increased
8
Reduced
3
Closed
4
Top Buys
| 1 |
THRD
Third Harmonic Bio
THRD
|
$13.3M |
| 2 |
LAVA Therapeutics
LVTX
|
$2.49M |
| 3 |
Adverum Biotechnologies
ADVM
|
$2.07M |
| 4 |
Kezar Life Sciences
KZR
|
$1.75M |
| 5 |
ELEV
Elevation Oncology
ELEV
|
$1.53M |
Top Sells
Sector Composition
| 1 | Healthcare | 98.84% |
| 2 | Technology | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Atea Pharmaceuticals
AVIR
$267M
| $22.8M | 18.41% | 7,609,812 +1,500 | +0% | +$4.49K |
|
2
Aclaris Therapeutics
ACRS
$209M
| $21.8M | 17.65% | 14,250,000 | – | – |
|
|
THRD
3
DELISTED
Third Harmonic Bio
THRD
| $13.3M | 10.74% | +3,824,417 | New | +$13.3M |
|
|
4
Adverum Biotechnologies
ADVM
$64.6M
| $12M | 9.7% | 2,742,317 +474,253 | +21% | +$2.07M |
|
5
AN2 Therapeutics
ANTX
$30.1M
| $7.82M | 6.33% | 5,749,432 | – | – |
|
6
Instil Bio
TIL
$182M
| $7.23M | 5.85% | 416,720 +16,720 | +4% | +$290K |
|
7
ESSA Pharma
EPIX
$11.4M
| $6.67M | 5.4% | 4,221,546 | – | – |
|
8
Oramed Pharmaceuticals
ORMP
$90.2M
| $6.46M | 5.23% | 3,020,748 +376,841 | +14% | +$806K |
|
|
IMA
9
ImageneBio, Inc. Common Stock
IMA
$150M
| $4.75M | 3.84% | 3,710,803 +124,937 | +3% | +$160K |
|
10
PMV Pharmaceuticals
PMVP
$74.2M
| $4.08M | 3.31% | 3,747,612 +280,928 | +8% | +$306K |
|
|
WHWK
11
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $3.36M | 2.72% | 1,890,245 -209,755 | -10% | -$373K |
|
|
12
LAVA Therapeutics
LVTX
$41.3M
| $2.49M | 2.02% | +1,960,610 | New | +$2.49M |
|
|
13
Kezar Life Sciences
KZR
$28.9M
| $1.99M | 1.61% | 408,138 +359,470 | +739% | +$1.75M |
|
|
ELEV
14
DELISTED
Elevation Oncology
ELEV
| $1.53M | 1.24% | +5,890,934 | New | +$1.53M |
|
15
Astrotech Corp
ASTC
$8.72M
| $1.43M | 1.16% | 220,410 | – | – |
|
|
CNTB
16
Connect Biopharma
CNTB
$115M
| $1.15M | 0.93% | 2,093,232 | – | – |
|
|
SAGE
17
DELISTED
Sage Therapeutics
SAGE
| $1.07M | 0.87% | +135,095 | New | +$1.07M |
|
18
Athira Pharma
ATHA
$15.3M
| $912K | 0.74% | 3,200,667 +424,782 | +15% | +$121K |
|
19
Milestone Pharmaceuticals
MIST
$156M
| $909K | 0.74% | 1,136,091 | – | – |
|
20
Lisata Therapeutics
LSTA
$19.9M
| $510K | 0.41% | 216,853 -67,816 | -24% | -$159K |
|
|
TSBX
21
DELISTED
Turnstone Biologics
TSBX
| $452K | 0.37% | +1,103,386 | New | +$452K |
|
22
VistaGen Therapeutics
VTGN
$102M
| $375K | 0.3% | 150,000 | – | – |
|
|
ALMS
23
Alumis Inc. Common Stock
ALMS
$479M
| $305K | 0.25% | +49,627 | New | +$305K |
|
24
NextCure
NXTC
$13.5M
| $131K | 0.11% | 273,536 | – | – |
|
25
Verrica Pharmaceuticals
VRCA
$52.8M
| $77.2K | 0.06% | 174,651 | – | – |
|